Loading...
Favorable Effects of Tacrolimus Monotherapy on Myasthenia Gravis Patients
Background and Purpose: Tacrolimus (TAC) has been proven to be a rapid-acting, steroid-sparing agent for myasthenia gravis (MG) therapy. However, evidence related to the effectiveness of TAC alone is rare. Therefore, this study was performed to investigate the effect of TAC monotherapy in MG patient...
Na minha lista:
| Udgivet i: | Front Neurol |
|---|---|
| Main Authors: | , , , , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7652845/ https://ncbi.nlm.nih.gov/pubmed/33193063 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.594152 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|